呼吸系统疾病中顺势疗法和传统疗法的费用—效益评估
2009/03/18
方法：1998年10月～2003年5月期间，我们对在意大利托斯卡纳地区Lucca的Campo di Marte医院顺势疗法医疗中心就诊的233名慢性呼吸系统疾病患者中的105人进行了回顾性观察研究。应用解剖学、治疗学及化学分类系统（ATC）评估传统医疗药物的费用，并评估在顺势疗法医疗中心就诊前的1年里及顺势疗法治疗后的第1年和第2年的总费用。估计接受顺势疗法、长期服用传统药物的一组患者（包括8名哮喘患者和16名呼吸系统感染复发患者）其传统药物费用，并与配对组患者（包括16名哮喘患者和32名呼吸系统感染复发患者）的传统药物费用进行比较。
结果：呼吸系统疾病的特效药物治疗的费用在顺势疗法治疗的第1年降低46.3%（n=105，P<0.01），第2年降低47.5%（n=72，P<0.01）。顺势疗法治疗期间总的药物费用在顺势疗法治疗的第1年降低42.4%（P<0.01），第2年降低49.8%（N.S.）。慢性哮喘患者的费用分析表明，在第1年随访期后，接受顺势疗法的患者中特效药物的费用降低71.1%，而仅接受传统药物治疗的患者其费用增加12.3%，在第2年随访期后，接受顺势疗法的患者其费用降低54.4%，而仅接受传统药物治疗的患者其费用增加45.2%。呼吸系统感染复发的患者中，我们发现在第1年随访期间接受顺势疗法的患者中特效药物的费用降低35.8%，而对照组患者其费用增加8.6%，第2年随访期间两组患者的费用分别为降低43.6%和升高 7.8%。
结论：采用顺势疗法治疗呼吸系统疾病（哮喘、过敏、急性呼吸系统感染复发）会显著减少传统药物的使用并降低费用。顺势疗法的费用显著低于传统药物治疗的费用。
结论：采用顺势疗法治疗呼吸系统疾病（哮喘、过敏、急性呼吸系统感染复发）会显著减少传统药物的使用并降低费用。顺势疗法的费用显著低于传统药物治疗的费用。
（苏楠 审校）
Rossi E, et al. Homeopathy. 2009 Jan;98(1):2-10
Rossi E, et al. Homeopathy. 2009 Jan;98(1):2-10
Rossi E, et al. Homeopathy. 2009 Jan;98(1):2-10.
Cost-benefit evaluation of homeopathic versus conventional therapy in respiratory diseases.
METHODS: A retrospective observational study was conducted on 105 out of 233 patients suffering from chronic respiratory disease attending the Homeopathic Clinic of the Campo di Marte Hospital in Lucca (Tuscany, Italy) between October 1998 and May 2003. We assessed the cost of conventional medicinal products using Anatomic Therapeutic Chemical (ATC) classification, specific for the pathology in question, and the general costs in the year preceding the first appointment at the Homeopathic Clinic vs. the first and second year subsequent to homeopathic treatment. The costs of conventional drugs for a group of patients affected by asthma (8 patients) and recurrent respiratory infections (16 patients) with long term use of conventional medicine treated by homeopathy were compared with the expenses of conventional drugs of a matched group of 16 and 32 patients, respectively.
RESULTS: Costs of pharmacological therapy specific for respiratory diseases were reduced by 46.3% (n=105) in the first year (P<0.01); and by 47.5% (n=72) in the second year (P<0.01) of homeopathic treatment. Reduction in general drug costs during homeopathic therapy was 42.4% in the first year (P<0.01); and -49.8 in the second year (N.S.). Costs for patients affected by chronic asthma showed a reduction in expenses of 71.1% for specific medicines relative to the group in homeopathic treatment vs. an increase of 12.3% in the group treated only with conventional drugs after the first year of follow-up and, respectively, a reduction of -54.4% for homeopathic treatment vs. +45.2% after the second year. For patients with recurrent respiratory infections we found a reduction of 35.8% in the homeopathic group in the first year, compared to an increase 8.6% of costs for specific drugs in the control group; in the second year the respective figures were -43.6% versus +7.8% in the control group.
CONCLUSIONS: Homeopathic treatment for respiratory diseases (asthma, allergic complaints, Acute Recurrent Respiratory Infections) was associated with a significant reduction in the use and costs of conventional drugs. Costs for homeopathic therapy are significantly lower than those for conventional pharmacological therapy.
RESULTS: Costs of pharmacological therapy specific for respiratory diseases were reduced by 46.3% (n=105) in the first year (P<0.01); and by 47.5% (n=72) in the second year (P<0.01) of homeopathic treatment. Reduction in general drug costs during homeopathic therapy was 42.4% in the first year (P<0.01); and -49.8 in the second year (N.S.). Costs for patients affected by chronic asthma showed a reduction in expenses of 71.1% for specific medicines relative to the group in homeopathic treatment vs. an increase of 12.3% in the group treated only with conventional drugs after the first year of follow-up and, respectively, a reduction of -54.4% for homeopathic treatment vs. +45.2% after the second year. For patients with recurrent respiratory infections we found a reduction of 35.8% in the homeopathic group in the first year, compared to an increase 8.6% of costs for specific drugs in the control group; in the second year the respective figures were -43.6% versus +7.8% in the control group.
CONCLUSIONS: Homeopathic treatment for respiratory diseases (asthma, allergic complaints, Acute Recurrent Respiratory Infections) was associated with a significant reduction in the use and costs of conventional drugs. Costs for homeopathic therapy are significantly lower than those for conventional pharmacological therapy.
上一篇：
哮喘治疗中选择性PDE4抑制剂的随机、安慰剂对照研究
下一篇：
TNF-α阻滞剂治疗重症持续期哮喘患者的随机、双盲、安慰剂对照研究
